Comerica Bank
ADMA icon

Comerica Bank’s ADMA Biologics ADMA Stock Holding History

Comerica Bank’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$950K Sell
52,102
-720,532
-93% -$12.1M ﹤0.01% 1544
2025
Q3 		$11.3M Buy
772,634
+688,828
+822% +$11.8M 0.04% 391
2025
Q2 		$1.53M Buy
83,806
+3,889
+5% +$79.3K 0.01% 1285
2025
Q1 		$1.59M Sell
79,917
-1,202
-1% -$20.8K 0.01% 1242
2024
Q4 		$1.39M Sell
81,119
-445
-0.5% -$8.37K 0.01% 1354
2024
Q3 		$1.63M Buy
+81,564
New +$1.27M 0.01% 1254

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Comerica Bank's ADMA Position: Q4 2025 in Review

Comerica Bank reduced its ADMA Biologics (ADMA) stake by 93% in Q4 2025, selling an estimated $12.1M and leaving 52,102 shares worth $950K. The position accounts for ﹤0.01% of the portfolio, ranked #1544.

Comerica Bank first reported a position in ADMA in Q3 2024 and has held it in 6 quarters since. The position peaked at $11.3M in Q3 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q4 2025.

  • Comerica Bank held 52,102 shares of ADMA Biologics worth $950K as of Q4 2025.
  • Comerica Bank sold 720,532 ADMA Biologics shares in Q4 2025, an estimated $12.1M.
  • ADMA Biologics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #1544 holding.
  • Comerica Bank first reported a position in ADMA Biologics in Q3 2024 and has held it in 6 quarters since.
  • Comerica Bank's ADMA Biologics position peaked at $11.3M in Q3 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.